Αποτελέσματα Αναζήτησης
DOI: 10.1002/acr.24180. Abstract. Objective: To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations.
- Gout - StatPearls - NCBI Bookshelf
Specific goals guide the treatment of gout. During acute...
- Management of Acute and Recurrent Gout: A Clinical Practice Guideline ...
Recommendation 1: ACP recommends that clinicians choose...
- Gout - StatPearls - NCBI Bookshelf
9 Ιουν 2022 · This guideline replaces TA164 and ESNM23. Overview. This guideline covers the diagnosis and management of gout. It includes recommendations on diagnosing gout, managing flares, long-term management of gout and referral to specialist services. Who is it for? Healthcare professionals providing NHS-commissioned services.
30 Νοε 2019 · Specific goals guide the treatment of gout. During acute flares, the primary objective is to alleviate inflammation and symptoms. In the long term, the goal shifts toward reducing serum urate levels to suppress flare-ups and regression of tophi. General Principles of Therapy
The TFP recommended that an acute gouty arthritis attack should be treated with pharmacologic therapy (Evidence C), and that treatment should be preferentially initiated within 24 hours of onset of an acute gout attack (Evidence C).
3 Ιαν 2017 · Recommendation 1: ACP recommends that clinicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine to treat patients with acute gout. (Grade: strong recommendation, high-quality evidence).
To provide guidance for the management of gout, including indications for and optimal use of urate- lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations.
Oral colchicine is an appropriate first-line gout attack prophylaxis therapy, including with appro-priate dose adjustment in chronic kidney disease and for drug interactions, unless there is a lack of tolerance or medical contraindication. Low-dose NSAID therapy is an appropriate choice.
